86 related articles for article (PubMed ID: 12490109)
21. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
Ozata M; Bolu E; Sengül A; Altinsoy HI; Turan M; Corakci A; Hacibektasoglu A; Gundogan MA
Endocr J; 1996 Oct; 43(5):517-25. PubMed ID: 8980891
[TBL] [Abstract][Full Text] [Related]
22. The expression and distribution of S-100 protein and CD 83 in thyroid tissues of autoimmune thyroid diseases.
Xu W; Chen S; Huang J; Zheng Z; Chen L; Zhang W
Cell Mol Immunol; 2004 Oct; 1(5):378-82. PubMed ID: 16285898
[TBL] [Abstract][Full Text] [Related]
23. BLyS and April serum levels in patients with autoimmune thyroid diseases.
Fabris M; Grimaldi F; Villalta D; Picierno A; Fabro C; Bolzan M; De Vita S; Tonutti E
Autoimmun Rev; 2010 Jan; 9(3):165-9. PubMed ID: 19647102
[TBL] [Abstract][Full Text] [Related]
24. [Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease].
Zhang JA; Zhang J; Xu L; Mar H; Wu XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):630-2. PubMed ID: 16948912
[TBL] [Abstract][Full Text] [Related]
25. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
26. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.
Heufelder AE; Bahn RS
Clin Exp Immunol; 1993 May; 92(2):296-302. PubMed ID: 8097976
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of elevated serum sICAM-1 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):469-71. PubMed ID: 12768764
[TBL] [Abstract][Full Text] [Related]
28. Role of FNA in the medical management of minimally enlarged thyroid.
Kini U; Buch A; Bantwal G
Diagn Cytopathol; 2006 Mar; 34(3):196-200. PubMed ID: 16470863
[TBL] [Abstract][Full Text] [Related]
29. The presence of the antigliadin antibodies in autoimmune thyroid diseases.
Akçay MN; Akçay G
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201
[TBL] [Abstract][Full Text] [Related]
30. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
31. [The assessment of usefulness of humoral markers estimation in patients with autoimmune thyroid diseases].
Myśliwiec J; Okłota M; Nikołajuk A; Górska M
Pol Merkur Lekarski; 2005 Nov; 19(113):663-6. PubMed ID: 16498807
[TBL] [Abstract][Full Text] [Related]
32. [Increased serum PIVKA-II levels in hyperthyroidism].
Morimoto M; Takeda K; Ohara E; Nishimori Y; Hisahara T; Nishida M; Sugiura T
Rinsho Byori; 2001 Nov; 49(11):1146-50. PubMed ID: 11769563
[TBL] [Abstract][Full Text] [Related]
33. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
Sonnet E; Massart C; Gibassier J; Allannic H; Maugendre D
J Endocrinol Invest; 1999 Jun; 22(6):430-5. PubMed ID: 10435852
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG) during pregnancy in autoimmune thyroid disease: relationship to disease activity.
Scott RM; How J; Gerrie LM; Khir AS; Bewsher PD; Horne CH; Thomson AW
Clin Exp Immunol; 1985 Mar; 59(3):564-70. PubMed ID: 3838711
[TBL] [Abstract][Full Text] [Related]
36. [Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody].
Lian XL; Bai Y; Sun ML; Guo ZS; Dai WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):677-81. PubMed ID: 15663231
[TBL] [Abstract][Full Text] [Related]
37. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
Pedro AB; Romaldini JH; Americo C; Takei K
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
[TBL] [Abstract][Full Text] [Related]
38. [Concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients witt Graves' disease and thyroid associated orbitopathy].
Kulig G; Pilarska K; Kulig J
Przegl Lek; 2004; 61(12):1319-24. PubMed ID: 15850321
[TBL] [Abstract][Full Text] [Related]
39. The significance of FDG uptake in bilateral thyroid glands.
Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
